{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:54:55Z","timestamp":1777730095036,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12026-020-09129-5","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T04:02:21Z","timestamp":1591761741000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Downregulation of B regulatory cells and upregulation of T helper 1 cells in children with Gaucher disease undergoing enzyme replacement therapy"],"prefix":"10.1007","volume":"68","author":[{"given":"Asmaa M.","family":"Zahran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervat A. M.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Engy Adel","family":"Shafik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab Albadry M.","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8445-711X","authenticated-orcid":false,"given":"Omnia","family":"El-Badawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir M.","family":"Abo Elgheet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid I.","family":"Elsayh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"9129_CR1","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","volume":"372","author":"G Grabowsky","year":"2008","unstructured":"Grabowsky G. Phenotype, diagnosis and treatment of Gaucher disease. Lancet. 2008;372:1263\u201371.","journal-title":"Lancet"},{"issue":"1","key":"9129_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/asheducation.V2012.1.13.3797921","volume":"2012","author":"GA Grabowski","year":"2012","unstructured":"Grabowski GA. Gaucher disease and other storage disorders. Am Soc Hematol Educ Program. 2012;2012(1):13\u20138.","journal-title":"Am Soc Hematol Educ Program"},{"issue":"3","key":"9129_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1615\/critrevoncog.2013004503","volume":"18","author":"MK Pandey","year":"2013","unstructured":"Pandey MK, Grabowski GA. Immunological cells and functions in Gaucher disease. Crit Rev Oncog. 2013;18(3):197\u2013220. https:\/\/doi.org\/10.1615\/critrevoncog.2013004503.","journal-title":"Crit Rev Oncog"},{"key":"9129_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221\u201341.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"9129_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32(1):129\u201340. https:\/\/doi.org\/10.1016\/j.immuni.2009.11.009.","journal-title":"Immunity."},{"issue":"2","key":"9129_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","volume":"117","author":"Y Iwata","year":"2011","unstructured":"Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530\u201341. https:\/\/doi.org\/10.1182\/blood-2010-07-294249.","journal-title":"Blood."},{"issue":"9","key":"9129_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/ajh.23488","volume":"88","author":"W Bao","year":"2013","unstructured":"Bao W, Zhong H, Manwani D, Vasovic L, Uehlinger J, Lee MT, et al. Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease. Am J Hematol. 2013;88(9):736\u201340.","journal-title":"Am J Hematol"},{"issue":"16","key":"9129_CR8","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1182\/blood-2012-05-432575","volume":"120","author":"X Li","year":"2012","unstructured":"Li X, Zhong H, Bao W, Boulad N, Evangelista J, Haider MA, et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood. 2012;120(16):3318\u201325.","journal-title":"Blood."},{"issue":"1","key":"9129_CR9","first-page":"00003","volume":"1","author":"J Bouaziz","year":"2014","unstructured":"Bouaziz J, de Masson A, Bagot M, Bensussan A. IL-10 producing regulatory B cells: where are we? MOJ Immunol. 2014;1(1):00003.","journal-title":"MOJ Immunol"},{"issue":"10","key":"9129_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/intimm\/dxv038","volume":"27","author":"C Mauri","year":"2015","unstructured":"Mauri C, Menon M. The expanding family of regulatory B cells. Int Immunol. 2015;27(10):479\u201386.","journal-title":"Int Immunol"},{"issue":"6","key":"9129_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.imbio.2009.07.002","volume":"215","author":"A Balreira","year":"2010","unstructured":"Balreira A, Cavallari M, Miranda MCS, Arosa FA. Uncoupling between CD1d upregulation induced by retinoic acid and conduritol-B-epoxide and iNKT cell responsiveness. Immunobiology. 2010;215(6):505\u201313.","journal-title":"Immunobiology."},{"issue":"2","key":"9129_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1006\/bcmd.1999.0237","volume":"25","author":"L Lacerda","year":"1999","unstructured":"Lacerda L, Arosa FA, Lacerda R, Cabeda J, Porto G, Amaral O, et al. T cell numbers relate to bone involvement in Gaucher disease. Blood Cell Mol Dis. 1999;25(2):130\u20138.","journal-title":"Blood Cell Mol Dis"},{"issue":"45","key":"9129_CR13","doi-asserted-by":"publisher","first-page":"19473","DOI":"10.1073\/pnas.1003308107","volume":"107","author":"PK Mistry","year":"2010","unstructured":"Mistry PK, Liu J, Yang M, Nottoli T, McGrath J, Jain D, et al. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci. 2010;107(45):19473\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"9129_CR14","doi-asserted-by":"crossref","unstructured":"Stockinger B, Veldhoen M, Martin B, editors. Th17 T cells: linking innate and adaptive immunity. Seminars in immunology; 2007: Elsevier.","DOI":"10.1016\/j.smim.2007.10.008"},{"issue":"8","key":"9129_CR15","first-page":"388","volume":"106","author":"Y Shoenfeld","year":"1982","unstructured":"Shoenfeld Y, Gallant L, Shaklai M, Livni E, Djaldetti M, Pinkhas J. Gaucher\u2019s disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med. 1982;106(8):388\u201391.","journal-title":"Arch Pathol Lab Med"},{"key":"9129_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/TCRM.S6955","volume":"6","author":"O Goker-Alpan","year":"2010","unstructured":"Goker-Alpan O. Optimal therapy in Gaucher disease. Ther Clin Risk Manag. 2010;6:315.","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"9129_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1177\/1060028013500469","volume":"47","author":"LL Bennett","year":"2013","unstructured":"Bennett LL, Mohan D. Gaucher disease and its treatment options. Ann Pharmacother. 2013;47(9):1182\u201393.","journal-title":"Ann Pharmacother"},{"key":"9129_CR18","first-page":"82","volume":"12","author":"A Zimran","year":"2014","unstructured":"Zimran A, Elstein D. Management of Gaucher disease: enzyme replacement therapy. Pediatr Endocrinol Rev. 2014;12:82\u20137.","journal-title":"Pediatr Endocrinol Rev"},{"key":"9129_CR19","doi-asserted-by":"crossref","unstructured":"Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M et al., editors. Therapeutic goals in the treatment of Gaucher disease. Seminars in hematology; 2004: Elsevier.","DOI":"10.1053\/j.seminhematol.2004.07.009"},{"key":"9129_CR20","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/ajh.24056","volume":"90","author":"J Charrow","year":"2015","unstructured":"Charrow J, Scott CR. Long-term treatment outcomes in G aucher disease. Am J Hematol. 2015;90:S19\u201324.","journal-title":"Am J Hematol"},{"issue":"12","key":"9129_CR21","doi-asserted-by":"publisher","first-page":"e0168135","DOI":"10.1371\/journal.pone.0168135","volume":"11","author":"RP Limgala","year":"2016","unstructured":"Limgala RP, Ioanou C, Plassmeyer M, Ryherd M, Kozhaya L, Austin L, et al. Time of initiating enzyme replacement therapy affects immune abnormalities and disease severity in patients with gaucher disease. PLoS One. 2016;11(12):e0168135.","journal-title":"PLoS One"},{"issue":"1","key":"9129_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bcmd.2011.09.005","volume":"48","author":"F Camou","year":"2012","unstructured":"Camou F, Viallard J-F. Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy. Blood Cells Mol Dis. 2012;48(1):51.","journal-title":"Blood Cells Mol Dis"},{"issue":"7203","key":"9129_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335.","journal-title":"Nature."},{"issue":"6","key":"9129_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140(6):871\u201382.","journal-title":"Cell."},{"issue":"2","key":"9129_CR25","first-page":"205","volume":"10","author":"V Barak","year":"1999","unstructured":"Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, et al. Cytokines in Gaucher\u2019s disease. Eur Cytokine Netw. 1999;10(2):205\u201310.","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"9129_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","volume":"36","author":"A Bosma","year":"2012","unstructured":"Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C. Lipid-antigen presentation by CD1d+ B cells is essential for the maintenance of invariant natural killer T cells. Immunity. 2012;36(3):477\u201390.","journal-title":"Immunity."},{"issue":"8","key":"9129_CR27","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","volume":"189","author":"A Das","year":"2012","unstructured":"Das A, Ellis G, Pallant C, Lopes AR, Khanna P, Peppa D, et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol. 2012;189(8):3925\u201335. https:\/\/doi.org\/10.4049\/jimmunol.1103139.","journal-title":"J Immunol"},{"issue":"173","key":"9129_CR28","doi-asserted-by":"publisher","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","volume":"5","author":"F Flores-Borja","year":"2013","unstructured":"Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5(173):173ra23. https:\/\/doi.org\/10.1126\/scitranslmed.3005407.","journal-title":"Sci Transl Med"},{"issue":"1","key":"9129_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bcmd.2004.08.023","volume":"34","author":"O Rogowski","year":"2005","unstructured":"Rogowski O, Shapira I, Zimran A, Zeltser D, Elstein D, Attias D, et al. Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cell Mol Dis. 2005;34(1):26\u20139.","journal-title":"Blood Cell Mol Dis"},{"issue":"6","key":"9129_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00277-008-0441-8","volume":"87","author":"M De Fost","year":"2008","unstructured":"De Fost M, Out T, De Wilde F, Tjin E, Pals S, van Oers M, et al. Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature. Ann Hematol. 2008;87(6):439\u201349.","journal-title":"Ann Hematol"},{"key":"9129_CR31","doi-asserted-by":"crossref","unstructured":"Shemesh E, Deroma L, Bembi B, Deegan P, Hollak C, Weinreb NJ, et al. Enzyme replacement and substrate reduction therapy for Gaucher disease. Cochrane Database Syst Rev. 2015;3.","DOI":"10.1002\/14651858.CD010324.pub2"},{"issue":"10","key":"9129_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.molmed.2003.08.004","volume":"9","author":"DA Brooks","year":"2003","unstructured":"Brooks DA, Kakavanos R, Hopwood JJ. Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder. Trends Mol Med. 2003;9(10):450\u20133.","journal-title":"Trends Mol Med"},{"issue":"4","key":"9129_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ajh.2830290403","volume":"29","author":"G Marti","year":"1988","unstructured":"Marti G, Ryan E, Papadopoulos N, Filling-Katz M, Barton N, Fleischer T, et al. Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol. 1988;29(4):189\u201394.","journal-title":"Am J Hematol"},{"issue":"1","key":"9129_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4328\/JCAM.5418","volume":"9","author":"M Dondurmac\u0131","year":"2018","unstructured":"Dondurmac\u0131 M, Canda E, K\u00f6se M, U\u00e7ar SK, \u00c7oker M, Sa\u011f\u0131n F, et al. Higher levels of CD19+ leukocytes in Gaucher disease patients as a potential marker for malignancy. J Clin Anal Med. 2018;9(1):56\u201360.","journal-title":"J Clin Anal Med"},{"issue":"2","key":"9129_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2013.09.002","volume":"111","author":"MK Pandey","year":"2014","unstructured":"Pandey MK, Jabre NA, Xu Y-H, Zhang W, Setchell KD, Grabowski GA. Gaucher disease: chemotactic factors and immunological cell invasion in a mouse model. Mol Genet Metab. 2014;111(2):163\u201371.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"9129_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","volume":"23","author":"CE Hollak","year":"1997","unstructured":"Hollak CE, Evers L, Aerts JM, van Oers MH. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cell Mol Dis. 1997;23(2):201\u201312.","journal-title":"Blood Cell Mol Dis"},{"issue":"53","key":"9129_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bcmd.2014.07.020","volume":"4","author":"P Rodic","year":"2014","unstructured":"Rodic P, Kurtovic NK, Vukovic NS, Djordjevic M, Mitrovic M, Sumarac Z, et al. Flow cytometric assessment of lymphocyte subsets in Gaucher type 1 patients. Blood Cell Mol Dis. 2014;4(53):169\u201370.","journal-title":"Blood Cell Mol Dis"},{"issue":"5","key":"9129_CR38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.20050227","volume":"202","author":"DM Jelley-Gibbs","year":"2005","unstructured":"Jelley-Gibbs DM, Brown DM, Dibble JP, Haynes L, Eaton SM, Swain SL. Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med. 2005;202(5):697\u2013706.","journal-title":"J Exp Med"},{"issue":"2","key":"9129_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.humimm.2015.11.018","volume":"77","author":"MC Matta","year":"2016","unstructured":"Matta MC, Soares DC, Kerstenetzky MS, Freitas ACP, Kim CA, Torres LC. CD4+ CD25highFoxp3+ Treg deficiency in a Brazilian patient with Gaucher disease and lupus nephritis. Hum Immunol. 2016;77(2):196\u2013200.","journal-title":"Hum Immunol"},{"key":"9129_CR40","doi-asserted-by":"crossref","unstructured":"Sotiropoulos C, Theodorou G, Repa C, Marinakis T, Verigou E, Solomou E et al. Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease. JIMD Reports, Volume 18. Springer; 2014. p. 107\u201315.","DOI":"10.1007\/8904_2014_357"},{"issue":"10","key":"9129_CR41","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","volume":"21","author":"S Sakaguchi","year":"2009","unstructured":"Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol. 2009;21(10):1105\u201311.","journal-title":"Int Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-020-09129-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:23:09Z","timestamp":1623284589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-020-09129-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["9129"],"URL":"https:\/\/doi.org\/10.1007\/s12026-020-09129-5","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"10 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from the guardians of the controls and patients before enrollment in the study. All procedures complied with the Health and Human Ethical Clearance Committee guidelines for Clinical Research at Assiut University (IRB no. 17300210).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}